Is Zydelig a chemotherapy drug?

Q: Is Zydelig a chemotherapy drug?

Zydelig (idelalisib) is not a chemotherapy drug, but a targeted anticancer treatment taken twice daily by mouth. Targeted drug therapies like Zydelig work by blocking specific pathways that allow the cancer to grow uncontrolled. Zydelig is used in combination with rituximab (Rituxan) to treat chronic lymphocytic leukemia (CLL).

Official answer

by Drugs.com

Zydelig (generic name: idelalisib) is not a traditional chemotherapy drug, but is a targeted anticancer treatment taken twice daily by mouth. Targeted drug therapies like Zydelig work by blocking specific pathways that allow the cancer to grow uncontrolled. Zydelig is used in combination with rituximab (Rituxan) to treat chronic lymphocytic leukemia (CLL).

Targeted drug therapies find and attack specific types of cancer cells and may cause less damage to healthy cells, but common, serious and possibly deadly side effects may still occur with targeted drug therapies.

Chemotherapy works by more generally killing rapidly growing cancer cells, but also can affect normal, healthy cells, which can worsen side effects.

Why is Zydelig prescribed?

Zydelig is used together with rituximab (Rituxan) to treat chronic lymphocytic leukemia (CLL) in adults when CLL comes back after prior cancer treatment and when rituximab treatment alone may be used due to other health problems. CLL is a type of blood cancer.

Limitations of Use

Zydelig should not be used as the first medicine (first-line treatment) to treat anyone.

It also should not be used in combination with bendamustine and rituximab, or in combination with rituximab to treat people with certain non-Hodgkin lymphomas.

It is not known if Zydelig is safe and effective in children.

How does Zydelig work in cancer?

Zydelig (idelalisib) works by blocking a protein called phosphatidylinositol 3-kinase (PI3Kδ) delta in cancer cells that tells the cancer to grow. Zydelig is also called a PI3K inhibitor.

PI3Kδ is a protein which is found in normal and cancerous B cells. PI3Kδ is involved in the activation, viability, growth and migration of B-cells, a type of cell found in the immune system. By inhibiting PI3Kδ, Zydelig blocks the messaging (signaling) that keeps the B-cells growing, and in turn leads to the death of the cancer cells.

How do I take Zydelig?

Zydelig is given as one 150 mg tablet twice daily, swallowed whole, with or without food.

Take your medicine exactly as prescribed by your doctor. Do not change your dose or stop taking Zydelig without first talking to your healthcare provider.

Most patients will continue treatment until their disease worsens or they have unacceptable side effects.

Zydelig can cause common, serious or deadly side effects. You should review the side effects of this medicine before treatment. Learn more about Zydelig warnings, precaution and side effects here.

This is not all the information you need to know about Zydelig (idelalisib) for safe and effective use and does not take the place of your doctor’s directions. Review the full product information and discuss this information and any questions you have with your doctor or other health care provider.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.